These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6487495)

  • 1. Accuracy and clinical utility of simplified tests of antipyrine metabolism.
    Farrell GC; Zaluzny L
    Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine.
    Carrum G; Egan JM; Abernethy DR
    Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine metabolism during hepatic regeneration in the rat.
    Poulsen HE; Pilsgaard H
    Liver; 1985 Aug; 5(4):196-9. PubMed ID: 4058271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
    Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
    Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
    J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ; Purba HS; Park BK; Ward SA; Orme ML
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.
    Seyffer R; Eichelbaum M; Jensen JC; Klotz U
    Eur J Clin Pharmacol; 1989; 37(3):231-3. PubMed ID: 2612536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.